Trexquant Investment’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-54,239
| Closed | -$271K | – | 1627 |
|
|
2021
Q1 | $271K | Buy |
54,239
+39,665
| +272% | +$198K | 0.02% | 808 |
|
|
2020
Q4 | $184K | Buy |
+14,574
| New | +$184K | 0.02% | 905 |
|
|
2020
Q2 | – | Sell |
-17,631
| Closed | -$156K | – | 1571 |
|
|
2020
Q1 | $156K | Buy |
+17,631
| New | +$156K | 0.01% | 1007 |
|
|
2019
Q3 | – | Sell |
-11,534
| Closed | -$138K | – | 1183 |
|
|
2019
Q2 | $138K | Sell |
11,534
-4,334
| -27% | -$51.9K | 0.01% | 724 |
|
|
2019
Q1 | $192K | Buy |
+15,868
| New | +$192K | 0.01% | 876 |
|
|
2017
Q1 | – | Sell |
-22,288
| Closed | -$229K | – | 1383 |
|
|
2016
Q4 | $229K | Buy |
+22,288
| New | +$229K | 0.04% | 763 |
|
|
2016
Q2 | – | Sell |
-49,568
| Closed | -$677K | – | 1174 |
|
|
2016
Q1 | $677K | Buy |
49,568
+25,488
| +106% | +$348K | 0.08% | 425 |
|
|
2015
Q4 | $457K | Buy |
+24,080
| New | +$457K | 0.04% | 718 |
|